Skip to main content

The complexities of coordinated enrollment to meet or exceed timelines are inherent with vaccine trials. Equally essential is the maintenance of high retention rates for quality data results. For this H5N1 Vaccine Study, the initial CRO was unable to accept the contract terms of the Sponsor. The trial execution was further delayed by that CRO’s proposed Investigator Meeting 10 weeks from the contract approval.